Egypt
· Delayed Price · Currency is EGP AXPH Statistics
Total Valuation
Alexandria Co. For Pharmaceuticals & Chemical Industries has a market cap or net worth of EGP 1.15 billion. The enterprise value is 1.01 billion.
| Market Cap | 1.15B |
| Enterprise Value | 1.01B |
Important Dates
The next estimated earnings date is Wednesday, October 16, 2024.
| Earnings Date | Oct 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Alexandria Co. For Pharmaceuticals & Chemical Industries has 5.00 million shares outstanding.
| Shares Outstanding | 5.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.28% |
| Owned by Institutions (%) | n/a |
| Float | 967,353 |
Valuation Ratios
The trailing PE ratio is 5.45.
| PE Ratio | 5.45 |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| PB Ratio | 1.49 |
| P/FCF Ratio | 13.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.45, with an EV/FCF ratio of 11.77.
| EV / Earnings | 4.80 |
| EV / Sales | 0.56 |
| EV / EBITDA | 3.45 |
| EV / EBIT | 3.97 |
| EV / FCF | 11.77 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.82 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.04 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.71% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +48.71% |
| 50-Day Moving Average | 218.14 |
| 200-Day Moving Average | 212.35 |
| Relative Strength Index (RSI) | 66.86 |
| Average Volume (20 Days) | 409 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of EGP 1.80 billion and earned 210.10 million in profits. Earnings per share was 42.02.
| Revenue | 1.80B |
| Gross Profit | 382.88M |
| Operating Income | 253.99M |
| Pretax Income | 274.31M |
| Net Income | 210.10M |
| EBITDA | 291.90M |
| EBIT | 253.99M |
| Earnings Per Share (EPS) | 42.02 |
Balance Sheet
The company has 141.04 million in cash and 3.52 million in debt, giving a net cash position of 137.52 million or 27.50 per share.
| Cash & Cash Equivalents | 141.04M |
| Total Debt | 3.52M |
| Net Cash | 137.52M |
| Net Cash Per Share | 27.50 |
| Equity (Book Value) | 771.09M |
| Book Value Per Share | 154.22 |
| Working Capital | 414.22M |
Cash Flow
In the last 12 months, operating cash flow was 162.17 million and capital expenditures -76.53 million, giving a free cash flow of 85.64 million.
| Operating Cash Flow | 162.17M |
| Capital Expenditures | -76.53M |
| Free Cash Flow | 85.64M |
| FCF Per Share | 17.13 |
Margins
Gross margin is 21.26%, with operating and profit margins of 14.10% and 11.67%.
| Gross Margin | 21.26% |
| Operating Margin | 14.10% |
| Pretax Margin | 15.23% |
| Profit Margin | 11.67% |
| EBITDA Margin | 16.21% |
| EBIT Margin | 14.10% |
| FCF Margin | 4.75% |
Dividends & Yields
This stock pays an annual dividend of 13.00, which amounts to a dividend yield of 5.68%.
| Dividend Per Share | 13.00 |
| Dividend Yield | 5.68% |
| Dividend Growth (YoY) | 6.56% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 37.88% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.68% |
| Earnings Yield | 18.35% |
| FCF Yield | 7.48% |
Stock Splits
The last stock split was on December 11, 2014. It was a forward split with a ratio of 1.11111111.
| Last Split Date | Dec 11, 2014 |
| Split Type | Forward |
| Split Ratio | 1.11111111 |